The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in research because ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Tim Sandry has an early form of Alzheimer’s disease, but considers himself fortunate to have started treatment with a promising new drug. “If there is a chance this will slow the progression ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...

By obtaining high-resolution images of Alzheimer’s disease-affected brain cells as the condition progresses, researchers have identified the specific neurons that are damaged. The information the ...

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...